The congress is a biennial meeting of international STI researchers and practitioners.
Community pharmacists support more involved role in customers’ HIV treatment
Community pharmacists in the United States have a unique opportunity to consult with customers about HIV treatment when selling over-the-counter HIV tests, according to a study by researchers at the Indiana University School of Public Health-Bloomington, the Rural Center for AIDS/STD Prevention and Butler University College of Pharmacy and Health Sciences.
In a study lead by Beth Meyerson, co-director of the Rural Center for AIDS/STD Prevention, licensed community pharmacists in Indiana reported that they wanted an active consultation role when customers purchased over-the-counter HIV tests. A rapid HIV home test kit, approved by FDA in the summer of 2012, is being sold through the U.S in pharmacies and on the Internet.
“Pharmacists understood the benefit of greater access to HIV testing, but they felt that their role as pharmacists was beyond that of OTC test seller,” Meyerson said. “Instead, pharmacists saw themselves as health consultants and wished to build on the strong relationships that they have with customers during the point at which they sell the test.
“The pharmacy system could be an effective environment for HIV consultation because it would help to strengthen the current system of linkage to care,” Meyerson said. Currently, 20 percent of those living with HIV in the U.S. do not yet know it; but among those who do, only 24 percent are in treatment with suppressed viral loads. “This essentially means that people are not testing for HIV, that they are not properly linked to treatment when they do test positive, and they are not maintained in care.”
She said rural communities have the most to gain from an engaged pharmacy environment because these communities often lack an HIV testing and treatment infrastructure, and people often feel stigmatized about HIV testing.
“If pharmacists are engaged and supportive, then it might help to increase the number of those who test for HIV and also the number of people linked to HIV treatment,” she said.
The study is one of several studies presented by Meyerson and IU School of Public Health-Bloomington colleagues at the STI & AIDS World Congress. Co-authors of “More Than Just Selling the Test: Pharmacist Opinion About the Sale of Over-the-Counter HIV Rapid Tests,” include Priscilla T. Ryder and Kelsey Coy, Butler University College of Pharmacy and Health Sciences; and Christiana von Hippel, IU School of Public Health-Bloomington and the Rural Center for AIDS/STD Prevention. The study was supported by the Indiana Clinical and Translational Sciences Institute.